Regenerative Medicine Breakthrough: Rigenera® Technology Offers Minimally Invasive Solution with Rapid Results
Regenerative medicine is paving the way for innovative treatments for a wide range of pathologies affecting patients today. One of the most groundbreaking technologies in this field is the patented Rigenera® technology, which promises to revolutionize current treatments in various therapeutic areas.
The Rigenera® technology, based on Autologous Micrografting Technology (AMT), harnesses the regenerative potential of the body’s own mesenchymal cells or adult stem cells. By transferring these cells to damaged tissues, the technology triggers therapeutic responses that help restore cellular communication and promote healing through biological mechanisms.
What sets Rigenera® apart is its minimally invasive nature and rapid results, with a single intervention typically performed in less than half an hour without the need for hospitalization. Being an autologous and homologous treatment, it eliminates the risk of rejection and enhances treatment specificity by using the patient’s own cells.
One of the key applications of Rigenera® technology is in the treatment of osteoarthritis, a degenerative joint disease that affects millions of people worldwide. With an estimated 30% of individuals over 40 suffering from osteoarthritis, the technology offers a promising solution to relieve pain, improve mobility, and halt the progression of the disease with just one intervention.
In a significant development for the field of regenerative medicine, Regenera Activa Worldwide and Rigenera HBW have merged to form Remedi, a global powerhouse in this sector. The merger aims to expand the reach of Rigenera® technology and drive further innovation in regenerative treatments.
The collaboration between these biotechnology companies has already shown remarkable success, with over 50,000 doctors worldwide using Rigenera® technology and more than 400,000 treatments performed in the past decade. This partnership is set to transform the landscape of regenerative medicine and benefit millions of patients.
Beyond orthopedics and sports medicine, Rigenera® technology also offers applications in dermatology, general medicine, and traumatology for wound healing and tissue regeneration. Collaborations with organizations like NATO and the European Space Agency showcase the versatility and potential of this innovative technology.
With projects like the WHISPER initiative focusing on wound healing in space, Remedi is at the forefront of advancing regenerative medicine for a wide range of healthcare challenges. Through the regenerative power of the body’s own cells, Rigenera® technology is poised to revolutionize medicine and improve the health and well-being of countless individuals worldwide.